Genius Group, FingerMotion, and BlueFlare have signed a binding agreement to develop a second 100 MW high-performance computing (HPC) campus in Alberta's Brooks Corridor, expanding their GENIUSpark Alberta initiative. The first site, Brooks Campus No. 1, is a permitted 9.9 MW facility expected to be operational by early 2027, with non-binding interest already received for up to 52.5 MW of capacity. This project aims to provide powered land and colocation services for HPC clients, supported by behind-the-meter natural gas power generation, and includes community benefits like local job creation and reskilling programs. The partners plan to announce client contracts and project financing soon, with potential revenues exceeding $100 million over five years once fully operational.
The agreement between Genius Group, FingerMotion, and BlueFlare for a new HPC campus provides context for technology sector activity on Pluang. For readers following the Technology sector, here is Pluang's market snapshot as of Nov 05, 2026 19:32 WIB: out of 150 priced US tech stocks, 50 rose and 95 fell. Notable movers include FSLY at USD 18.09 with a -14.00% change and 100% sell order activity, EPAM at USD 155.89 with a +13.49% change and 74% sell order activity, and RELY at USD 23.99 with a -11.41% change and 100% sell order activity.
On November 4, 2026, Shell plc repurchased a total of 1,876,276 shares across multiple trading venues including LSE, Chi-X, BATS, XAMS, CBOE, and TQEX. The shares were bought at prices ranging from £37.98 to £38.82 and €45.70 to €46.72, with an avera...
Dune has completed a SOC 2 Type II examination with no exceptions, providing institutional clients with verified assurance of its data security standards. This milestone comes as tokenized real-world assets doubled to $32.6 billion and stablecoin mar...
Northern Discovery Metals has finalized the acquisition of a 100% interest in the Cibola copper-gold project in British Columbia from Orogen Royalties. The project covers about 3,567 hectares near Houston, BC, in a region known for porphyry copper de...
Opus Genetics has finished dosing the higher-dose Cohort 2 in its Phase 1/2 trial of OPGx-BEST1, a gene therapy for BEST1-related inherited retinal diseases like Best vitelliform macular dystrophy and autosomal recessive bestrophinopathy. Cohort 2 en...
Perimeter Group Inc. announced a net income of $304.5 million for Q3 2026, reversing a prior year loss of $90.7 million, with net sales up 24% to $389.9 million. Growth was driven by a 14% increase in Fire Safety sales and an 84% surge in Specialty P...
